Selective digestive tract decontamination: A tough pill to swallow

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 20, Issue 1, 2009, Pages 9-11

  Laupland, Kevin B ^a,c   Fisman, David N ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; TOBRAMYCIN;

ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CULTURE MEDIUM; DIGESTIVE SYSTEM; FUNGEMIA; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROPHYLAXIS; SCORING SYSTEM;

EID: 64849087978     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/290130     Document Type: Article

References (17)

1. Richards MJ, Edwards JR, Culver DH, Gaynes R P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000;21:510-5.
2. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-40.
3. Kollef M. SMART approaches for reducing nosocomial infections in the ICU. Chest 2008;134:447-56.
4. de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
5. de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomised controlled trial. Lancet 2003;362:1011-6.
6. Krueger WA, Lenhart F P, Neeser G, et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: A prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 2002;166:1029-37.
7. Liberati A, D'Amico R, Pifferi, Torri V, Brazzi L. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2004(1):CD000022.
8. de La Cal MA, Cerda E, Garcia-Hierro P, et al. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: A randomized, placebo-controlled, double-blind trial. Ann Surg 2005;241:424-30.
9. Stoutenbeek C P, van Saene HK, Little RA, Whitehead A. The effect of selective decontamination of the digestive tract on mortality in multiple trauma patients: A multicenter randomized controlled trial. Intensive Care Med 2007;33:261-70.
10. Camus C, Bellissant E, Sebille V, et al. Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Crit Care Med 2005;33:307-14.
11. van Saene HK, Petros AJ, Ramsay G, Baxby D. All great truths are iconoclastic: Selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med 2003;29:677-90.
12. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
13. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007;60:613-8.
14. Silvestri L, van Saene HK, de la Cal MA, et al. Surviving sepsis campaign needed consensus to exclude selective decontamination of the digestive tract. Crit Care Med 2008;36:2716-7.
15. Dellinger R P, Levy MM, Carlet JM, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
16. Muscedere J, Dodek P, Keenan S, Fowler R, Cook D, Heyland D. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care 2008;23:126-37.
17. Bonten MJ. Selective digestive tract decontamination - will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic? Clin Infect Dis 2006;43(Suppl 2):S70-4.